Fund profile by ISIN IE000L4EH2K5
Invesco S&P World Health Care ESG UCITS ETF Acc
Research Invesco S&P World Health Care ESG UCITS ETF Acc by ISIN IE000L4EH2K5: TER 0.18%, domicile Ireland, accumulating, and 1-year price performance +18.1%.
ISINIE000L4EH2K5
TER0.18%
DomicileIreland
Distribution policyAccumulating
IndexS&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care
Fund size11M
Holdings73
1-year price performance+18.1%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| WHCE.SW | SW | USD | Ireland | €45K | 7,544 |
| WDHE.MI | ETFP | EUR | Ireland | €22K | 3,710 |
| WH2E.DE | XETRADefault at German brokers | EUR | Ireland | €18K | 3,095 |
| WHCE.L | LSE | USD | Ireland | €15K | 2,605 |
| WHCG.L | LSE | GBX | Ireland | €6K | 978 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 66.05% of the fund, which holds 73 positions in total. As of 2026-10-12.
| Holding | Symbol | Weight |
|---|---|---|
| Eli Lilly and Co | LLY | 16.76% |
| AbbVie Inc | ABBV | 12.03% |
| Merck & Co Inc | MRK | 7.44% |
| AstraZeneca PLC | AZN.L | 4.72% |
| Gilead Sciences Inc | GILD | 4.65% |
| Novartis AG Registered Shares | NOVN.SW | 4.49% |
| Roche Holding AG Ordinary Shares new | ROP.SW | 4.30% |
| Amgen Inc | AMGN | 4.16% |
| Thermo Fisher Scientific Inc | TMO | 3.87% |
| Abbott Laboratories | ABT | 3.63% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.